BC052486 activators are a class of chemical compounds designed to specifically enhance the activity of the BC052486 gene or its associated protein product. The BC052486 gene, though not widely characterized, is thought to play a role in various cellular processes based on its genetic and protein interactions. Activators of BC052486 function by binding to specific sites on the gene's promoter region or directly interacting with the protein, thereby increasing the gene's transcriptional activity or the protein's functional activity. This upregulation can lead to an increase in the expression levels of the BC052486 protein, which may have downstream effects on cellular pathways that are influenced by this gene. By modulating the activity of BC052486, these activators are valuable tools for studying the gene's function and its role in cellular processes such as signal transduction, metabolism, and gene regulation.
The development of BC052486 activators involves a detailed understanding of the gene's regulatory elements, protein structure, and interaction networks. Researchers typically use techniques such as chromatin immunoprecipitation (ChIP) sequencing to identify potential binding sites for activators on the gene's promoter region, as well as protein crystallography and molecular docking to understand the protein's structure and potential activator binding sites. High-throughput screening of chemical libraries is a common approach to identify compounds that can effectively increase the activity of BC052486. Once lead compounds are identified, they undergo structure-activity relationship (SAR) studies to refine their chemical structure, optimizing properties such as binding affinity, specificity, and stability. These studies are crucial for enhancing the efficacy of the activators while minimizing off-target effects on other genes or proteins. Additionally, factors like solubility, cell permeability, and metabolic stability are carefully considered to ensure that the activators can function effectively in various experimental conditions. Through these comprehensive research and development processes, BC052486 activators serve as essential tools for exploring the biological functions of this gene and its impact on cellular dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenolic compound, activates Tmem74bos indirectly by modulating the SIRT1/NF-κB pathway. It enhances SIRT1 activity, suppressing NF-κB, thereby influencing Tmem74bos expression. Resveratrol's anti-inflammatory properties contribute to the indirect activation of Tmem74bos through modulation of key cellular pathways. | ||||||
Caffeic Acid | 331-39-5 | sc-200499 sc-200499A | 1 g 5 g | $32.00 $62.00 | 1 | |
Caffeic acid, a phenolic compound, indirectly activates Tmem74bos by inhibiting the NF-κB pathway. By suppressing NF-κB activation, it modulates Tmem74bos expression, impacting cellular responses. Caffeic acid’s anti-inflammatory actions through NF-κB inhibition contribute to the indirect activation of Tmem74bos, revealing its potential as a regulatory compound. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, indirectly activates Tmem74bos by dampening NF-κB signaling. Its inhibition of NF-κB influences Tmem74bos expression, indicating a potential indirect activation mechanism. BAY 11-7082's role in modulating inflammatory responses through NF-κB makes it a candidate for influencing Tmem74bos expression and function. | ||||||
JNK Inhibitor VIII | 894804-07-0 | sc-202673 | 5 mg | $272.00 | 2 | |
JNK Inhibitor VIII indirectly activates Tmem74bos by inhibiting the JNK pathway. Suppression of JNK activity affects Tmem74bos expression, revealing a potential indirect activation mechanism. The impact on cellular responses through JNK inhibition establishes a link between this chemical and the modulation of Tmem74bos expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, indirectly activates Tmem74bos by modulating the p38 MAPK pathway. Its inhibition influences Tmem74bos expression, suggesting an indirect activation mechanism. SB203580’s role in regulating cellular responses through p38 MAPK inhibition highlights its potential to impact Tmem74bos expression and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, indirectly activates Tmem74bos by modulating the MAPK pathway. Inhibition of MEK alters Tmem74bos expression, indicating a potential indirect activation mechanism. PD98059's role in influencing cellular responses through MAPK pathway inhibition establishes a potential link with the regulation of Tmem74bos expression. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662, an AMP-activated protein kinase (AMPK) activator, indirectly activates Tmem74bos by influencing the AMPK pathway. Activation of AMPK affects Tmem74bos expression, indicating a potential indirect activation mechanism. A769662’s role in modulating cellular responses through AMPK activation establishes a potential link with the regulation of Tmem74bos expression. | ||||||
SC514 | 354812-17-2 | sc-205504 sc-205504A | 5 mg 10 mg | $67.00 $91.00 | 13 | |
SC-514, an IKK-2 inhibitor, indirectly activates Tmem74bos by modulating the NF-κB pathway. Inhibition of IKK-2 influences Tmem74bos expression, suggesting an indirect activation mechanism. SC-514's role in regulating cellular responses through NF-κB inhibition establishes a connection between this chemical and the modulation of Tmem74bos expression. | ||||||